Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Guelph

$24,800.00

Identification of predictive microRNA biomarkers for improved success of assisted reproductive technologies

FY 2015-16

Summary
Assisted reproductive technologies (ART) encompass evidence-based approaches to reproduction that lead to improved fertility through the integration of pharmacological, clinical and laboratory procedures. Growth in the requirement for improved fertility outcomes has lead to the emergence of clinic-based industries in both the medical and veterinary sectors that are dedicated to enhancing the success of ART procedures such as in vitro fertilization (IVF) and embryo transfer (ET). These procedures involve the acquisition of oocytes (eggs) from the mother, fertilizing them with sperm from the father, and incubating them through the earliest phases of development prior to reintroduction into the mother. With this proposal, we aim to initiate a partnership with ONE Fertility, an industry-leading Ontario Fertility clinic, to address an important problem affecting the entire industry, namely, how to identify embryos with the highest probability of a successful pregnancy. Embryos from human ART clinics cannot be readily used to develop improvements on existing technologies as any subsequent pregnancy might be jeopardized. Furthermore, many of the ""models"" such as mice that are often used in medical research are markedly different from humans. In contrast, the developmental events are highly similar between humans and cattle, and we routinely employ similar IVF protocols for this species. Importantly, preliminary studies have shown that small specific RNA markers are critical for development in both human and bovine embryos and have the potential to reflect the likelihood of a successful pregnancy. Using bovine embryos, we will examine several such markers that are also present in humans to determine how they change and whether the changes are associated with successful embryo growth. We will also determine whether the levels change in the media in which the embryos are grown. If successful, this project will establish important principles and a key model that can be employed by the ART industry to improve reproductive success.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
486352-2015
Name nom
LaMarre, Jonathan
Department département
Biomedical Sciences
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
24800
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5505
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal reproduction
Research subject fr
Reproduction animale
Partie
1
Nb partie
1
Application title
Identification of predictive microRNA biomarkers for improved success of assisted reproductive technologies
Keyword
NSERC
Application summary
Assisted reproductive technologies (ART) encompass evidence-based approaches to reproduction that lead to improved fertility through the integration of pharmacological, clinical and laboratory procedures. Growth in the requirement for improved fertility outcomes has lead to the emergence of clinic-based industries in both the medical and veterinary sectors that are dedicated to enhancing the success of ART procedures such as in vitro fertilization (IVF) and embryo transfer (ET). These procedures involve the acquisition of oocytes (eggs) from the mother, fertilizing them with sperm from the father, and incubating them through the earliest phases of development prior to reintroduction into the mother. With this proposal, we aim to initiate a partnership with ONE Fertility, an industry-leading Ontario Fertility clinic, to address an important problem affecting the entire industry, namely, how to identify embryos with the highest probability of a successful pregnancy. Embryos from human ART clinics cannot be readily used to develop improvements on existing technologies as any subsequent pregnancy might be jeopardized. Furthermore, many of the ""models"" such as mice that are often used in medical research are markedly different from humans. In contrast, the developmental events are highly similar between humans and cattle, and we routinely employ similar IVF protocols for this species. Importantly, preliminary studies have shown that small specific RNA markers are critical for development in both human and bovine embryos and have the potential to reflect the likelihood of a successful pregnancy. Using bovine embryos, we will examine several such markers that are also present in humans to determine how they change and whether the changes are associated with successful embryo growth. We will also determine whether the levels change in the media in which the embryos are grown. If successful, this project will establish important principles and a key model that can be employed by the ART industry to improve reproductive success.